Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron

被引:1
作者
Chemaitelly, Hiam [1 ,2 ,3 ]
Ayoub, Houssein H. [4 ]
Coyle, Peter [5 ,6 ,7 ]
Tang, Patrick [8 ]
Hasan, Mohammad R. [9 ]
Yassine, Hadi M. [5 ,10 ]
Al Thani, Asmaa A. [5 ,10 ]
Al-Kanaani, Zaina [6 ]
Al-Kuwari, Einas [6 ]
Jeremijenko, Andrew [6 ]
Kaleeckal, Anvar Hassan [6 ]
Latif, Ali Nizar [6 ]
Shaik, Riyazuddin Mohammad [6 ]
Abdul-Rahim, Hanan F. [11 ]
Nasrallah, Gheyath K. [5 ,10 ]
Al-Kuwari, Mohamed Ghaith [12 ]
Butt, Adeel A. [3 ,6 ,13 ]
Al-Romaihi, Hamad Eid [14 ]
Al-Thani, Mohamed H. [14 ]
Al-Khal, Abdullatif [6 ]
Bertollini, Roberto [14 ]
Abu-Raddad, Laith J. [1 ,2 ,3 ,11 ,15 ]
机构
[1] Cornell Univ, Qatar Fdn Educ City, Infect Dis Epidemiol Grp, Weill Cornell Med Qatar, Doha, Qatar
[2] Cornell Univ, Qatar Fdn Educ City, World Hlth Org Collaborating Ctr Dis Epidemiol Ana, Sexually Transmitted Infect & Viral Hepatitis, Doha, Qatar
[3] Cornell Univ, Dept Populat Hlth Sci, Weill Cornell Med, New York, NY 10022 USA
[4] Qatar Univ, Coll Arts & Sci, Dept Math Stat & Phys, Math Program, Doha, Qatar
[5] Qatar Univ, Coll Hlth Sci, Dept Biomed Sci, QU Hlth, Doha, Qatar
[6] Hamad Med Corp, Doha, Qatar
[7] Queens Univ, Wellcome Wolfson Inst Expt Med, Belfast, North Ireland
[8] Sidra Med, Dept Pathol, Doha, Qatar
[9] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada
[10] Qatar Univ, Biomed Res Ctr, QU Hlth, Doha, Qatar
[11] Qatar Univ, Coll Hlth Sci, Dept Publ Hlth, QU Hlth, Doha, Qatar
[12] Primary Hlth Care Corp, Doha, Qatar
[13] Cornell Univ, Dept Med, Weill Cornell Med, New York, NY USA
[14] Minist Publ Hlth, Doha, Qatar
[15] Hamad Bin Khalifa Univ, Coll Hlth & Life Sci, Doha, Qatar
关键词
COVID-19; IMMUNITY; VACCINATION; INFECTION; VARIANTS; DESIGN;
D O I
10.1038/s41586-024-08511-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly evolved over short timescales, leading to the emergence of more transmissible variants such as Alpha and Delta1, 2-3. The arrival of the Omicron variant marked a major shift, introducing numerous extra mutations in the spike gene compared with earlier variants1,2. These evolutionary changes have raised concerns regarding their potential impact on immune evasion, disease severity and the effectiveness of vaccines and treatments1,3. In this epidemiological study, we identified two distinct patterns in the protective effect of natural infection against reinfection in the Omicron versus pre-Omicron eras. Before Omicron, natural infection provided strong and durable protection against reinfection, with minimal waning over time. However, during the Omicron era, protection was robust only for those recently infected, declining rapidly over time and diminishing within a year. These results demonstrate that SARS-CoV-2 immune protection is shaped by a dynamic interaction between host immunity and viral evolution, leading to contrasting reinfection patterns before and after Omicron's first wave. This shift in patterns suggests a change in evolutionary pressures, with intrinsic transmissibility driving adaptation pre-Omicron and immune escape becoming dominant post-Omicron, underscoring the need for periodic vaccine updates to sustain immunity.
引用
收藏
页码:1024 / 1031
页数:26
相关论文
共 83 条
  • [1] Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
    Abu-Raddad, L. J.
    Chemaitelly, H.
    Ayoub, H. H.
    AlMukdad, S.
    Yassine, H. M.
    Al-Khatib, H. A.
    Smatti, M. K.
    Tang, P.
    Hasan, M. R.
    Coyle, P.
    Al-Kanaani, Z.
    Al-Kuwari, E.
    Jeremijenko, A.
    Kaleeckal, A. H.
    Latif, A. N.
    Shaik, R. M.
    Abdul-Rahim, H. F.
    Nasrallah, G. K.
    Al-Kuwari, M. G.
    Butt, A. A.
    Al-Romaihi, H. E.
    Al-Thani, M. H.
    Al-Khal, A.
    Bertollini, R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (19) : 1804 - 1816
  • [2] Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Malek, Joel A.
    Ahmed, Ayeda A.
    Mohamoud, Yasmin A.
    Younuskunju, Shameem
    Ayoub, Houssein H.
    Al Kanaani, Zaina
    Al Khal, Abdullatif
    Al Kuwari, Einas
    Butt, Adeel A.
    Coyle, Peter
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Rahim, Hanan F. Abdul
    Yassine, Hadi M.
    Al Kuwari, Mohamed G.
    Al Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Bertollini, Roberto
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E1830 - E1840
  • [3] Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Bertollini, Roberto
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (11) : 1091 - 1093
  • [4] Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Bertollini, Roberto
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (08) : 799 - 800
  • [5] Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Ayoub, Houssein H.
    Coyle, Peter
    Malek, Joel A.
    Ahmed, Ayeda A.
    Mohamoud, Yasmin A.
    Younuskunju, Shameem
    Tang, Patrick
    Al Kanaani, Zaina
    Al Kuwari, Einas
    Butt, Adeel A.
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Abdul Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Yassine, Hadi M.
    Al Kuwari, Mohamed Ghaith
    Al Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Al Khal, Abdullatif
    Bertollini, Roberto
    [J]. PLOS MEDICINE, 2021, 18 (12)
  • [6] Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Bertollini, Roberto
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26) : 2487 - 2489
  • [7] Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Ayoub, Houssein H.
    Yassine, Hadi M.
    Benslimane, Fatiha M.
    Al Khatib, Hebah A.
    Tang, Patrick
    Hasan, Mohammad R.
    Coyle, Peter
    Al Kanaani, Zaina
    Al Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Rahim, Hanan F. Abdul
    Nasrallah, Gheyath K.
    Al Kuwari, Mohamed Ghaith
    Butt, Adeel A.
    Al Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Al Khal, Abdullatif
    Bertollini, Roberto
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (19): : 1930 - 1939
  • [8] Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Ayoub, Houssein H.
    Yassine, Hadi M.
    Benslimane, Fatiha M.
    Al Khatib, Hebah A.
    Tang, Patrick
    Hasan, Mohammad R.
    Coyle, Peter
    AlMukdad, Sawsan
    Al Kanaani, Zaina
    Al Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Abdul Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al Kuwari, Mohamed Ghaith
    Butt, Adeel A.
    Al Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Al Khal, Abdullatif
    Bertollini, Roberto
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E1188 - E1191
  • [9] SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Coyle, Peter
    Malek, Joel A.
    Ahmed, Ayeda A.
    Mohamoud, Yasmin A.
    Younuskunju, Shameem
    Ayoub, Houssein H.
    Al Kanaani, Zaina
    Al Kuwari, Einas
    Butt, Adeel A.
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Rahim, Hanan F. Abdul
    Nasrallah, Gheyath K.
    Yassine, Hadi M.
    Al Kuwari, Mohamed Ghaith
    Al Romaihi, Hamad Eid
    Al-Thani, Mohamed H.
    Al Khal, Abdullatif
    Bertollini, Roberto
    [J]. ECLINICALMEDICINE, 2021, 35
  • [10] Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Ayoub, Houssein H.
    Al Kanaani, Zaina
    Al Khal, Abdullatif
    Al Kuwari, Einas
    Butt, Adeel A.
    Coyle, Peter
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Owen, Robert C.
    Rahim, Hanan F. Abdul
    Al Abdulla, Samya A.
    Al Kuwari, Mohamed G.
    Kandy, Mujeeb C.
    Saeb, Hatoun
    Ahmed, Shazia Nadeem N.
    Al Romaihi, Hamad Eid
    Bansal, Devendra
    Dalton, Louise
    Al-Thani, Mohamed H.
    Bertollini, Roberto
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)